Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (21-30 of 364) with videos related to

Pageof 37
Sort By:
Cell Cycle (Georgetown, Tex.)|February 21, 2012
Reverse Warburg: straight to cancerLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Autophagy|November 16, 2011
The end of autophagic cell death?Shensi Shen, Oliver Kepp, Guido Kroemer
Oncoimmunology|September 14, 2020
Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancerOliver Kepp, Laurence Zitvogel, Guido Kroemer
Oncoimmunology|January 18, 2021
Ferroptosis becomes immunogenic: implications for anticancer treatmentsDaolin Tang, Oliver Kepp, Guido Kroemer
Oncoimmunology|January 30, 2014
Immune effectors required for the therapeutic activity of vorinostatOliver Kepp, Lorenzo Galluzzi, Guido Kroemer
Cell Research|January 15, 2014
MLKL regulates necrotic plasma membrane permeabilizationLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
The EMBO Journal|January 19, 2012
Enlightening the impact of immunogenic cell death in photodynamic cancer therapyLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Cell Cycle (Georgetown, Tex.)|July 22, 2010
A new role for cytoplasmic p53: binding and destroying double-stranded RNALorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Oncoimmunology|June 27, 2022
The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?Oliver Kepp, Lucillia Bezu, Guido Kroemer
Oncoimmunology|January 10, 2014
Immunogenic cell death in radiation therapyLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Pageof 37

Showing results (21-30 of 364) with videos related to

Sort By:
Pageof 37
Cell Cycle (Georgetown, Tex.)|February 21, 2012
Reverse Warburg: straight to cancerLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Autophagy|November 16, 2011
The end of autophagic cell death?Shensi Shen, Oliver Kepp, Guido Kroemer
Oncoimmunology|September 14, 2020
Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancerOliver Kepp, Laurence Zitvogel, Guido Kroemer
Oncoimmunology|January 18, 2021
Ferroptosis becomes immunogenic: implications for anticancer treatmentsDaolin Tang, Oliver Kepp, Guido Kroemer
Oncoimmunology|January 30, 2014
Immune effectors required for the therapeutic activity of vorinostatOliver Kepp, Lorenzo Galluzzi, Guido Kroemer
Cell Research|January 15, 2014
MLKL regulates necrotic plasma membrane permeabilizationLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
The EMBO Journal|January 19, 2012
Enlightening the impact of immunogenic cell death in photodynamic cancer therapyLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Cell Cycle (Georgetown, Tex.)|July 22, 2010
A new role for cytoplasmic p53: binding and destroying double-stranded RNALorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Oncoimmunology|June 27, 2022
The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?Oliver Kepp, Lucillia Bezu, Guido Kroemer
Oncoimmunology|January 10, 2014
Immunogenic cell death in radiation therapyLorenzo Galluzzi, Oliver Kepp, Guido Kroemer
Pageof 37